Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
This building houses comprehensive cancer services in a partnership with Dana-Farber/Brigham and Women's Cancer Center. [3] In 2009, they opened a comprehensive breast health service called The Breast Center. Milford Regional is affiliated with UMass Memorial Health Care as a major teaching hospital. [4]
Some patient portal applications enable patients to register and complete forms online, which can streamline visits to clinics and hospitals. Many portal applications also enable patients to request prescription refills online, order eyeglasses and contact lenses , access medical records , pay bills, review lab results, and schedule medical ...
Kenneth C. Anderson is an American hematologist-oncologist and cancer researcher who is primarily known for advances in the treatment of multiple myeloma.He directs the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana–Farber Cancer Institute and is the Kraft Family Professor of Medicine and Vice Chair of the Joint Program in Transfusion Medicine at Harvard ...
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Edward J. Benz Jr. is the former president of Dana–Farber Cancer Institute in Boston, Massachusetts., [1] and the Richard and Susan Smith Professor of Medicine [2] as well as a professor of genetics at Harvard Medical School. [3] He was named to the presidency of Dana-Farber in 2000, succeeding David G. Nathan. [4]
David M. Livingston (29 March 1941 – 17 October 2021) [1] was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. [2] Dr. Livingston joined the Harvard faculty in 1973. [3]
In July 2015, Haas-Kogan succeeded Jay Harris as Chair of the Department of Radiation Oncology at the Dana–Farber Cancer Institute, Brigham and Women’s Hospital (BWHC), and Boston Children’s Hospital. She was also appointed professor at Harvard Medical School and become an endowed professor of Radiation Oncology at BWHC. [3]